Seeking Alpha
View as an RSS Feed


View MarketScanners' Comments BY TICKER:
Latest  |  Highest rated
  • Decision Diagnostics Could Be The New Vringo [View article]
    $DECN There seems to be a lot of volume coming into the stock now. Volume precedes price.
    Oct 24, 2013. 08:45 PM | Likes Like |Link to Comment
  • Latest Research Suggests Amarin Value Now Higher As It Awaits FDA Approval [View article]
    Again, for those of you who have not read this (including the somewhat misinformed author of this article):

    More info here:

    Omthera Pharmaceuticals (Private, Not Rated) disclosed Phase 3 top-line results for Epanova

    l Epanova is a ultra-pure mixture of free fatty acids EPA and DHA

    l AMR101 is a omega-3 fatty acid, comprising ~96% ultra-pure EPA

    l Both are lipid-lowering drugs, targeting the large hypertriglyceridemia market

    l AMR101’s main advantage is that it does not raise LDL (bad cholesterol)

    l Omthera did not disclose LDL data, which prompted speculation that the drug might raise LDL

    l Krill oil based CaPre® not only seems to decrease triglycerides, but also appears to reduce LDL and to increase HDL (good cholesterol)
    Apr 30, 2012. 05:50 PM | 1 Like Like |Link to Comment
  • Solid Fundamental Bet: Shares Of Marine Omega-3 Phospholipids Leader Ready Climb [View article]
    Is it any wonder Garza has thousands of followers and the naysayers have two?

    As an analyst/reporter the man is right FAR more often than he is wrong and when it comes to NEPT. He is 1000% right.

    Some new reading materials for those who missed the HUGE run-up this week. Get a clue:
    Apr 27, 2012. 06:54 AM | Likes Like |Link to Comment
1 Like